What is Mirtazapine?
Mirtazapine is a tetracyclic antidepressant FDA-approved for treating major depressive disorder in adults, with a unique mechanism that increases both noradrenergic and specific serotonergic neurotransmission through blockade of central α2-adrenergic receptors and selective serotonin receptor antagonism. 1
Mechanism of Action
Mirtazapine works through a distinctive pharmacological profile that sets it apart from other antidepressants:
- Blocks presynaptic α2-adrenergic auto- and heteroreceptors, which increases release of both norepinephrine and serotonin 2, 3
- Selectively blocks 5-HT2 and 5-HT3 serotonin receptors while leaving 5-HT1 receptors unaffected, resulting in enhanced 5-HT1-mediated transmission 2, 4
- Potently blocks histamine H1 receptors, contributing to its sedative properties 3
- Has minimal effects on serotonin reuptake, muscarinic cholinergic receptors, and dopaminergic receptors 3
This combination earned mirtazapine the designation as a Noradrenergic and Specific Serotonergic Antidepressant (NaSSA) 2.
Clinical Efficacy
Depression Treatment
Mirtazapine demonstrates equivalent efficacy to other second-generation antidepressants for major depressive disorder, but with a notably faster onset of action 5:
- Shows statistically significant faster symptom improvement compared to citalopram, fluoxetine, paroxetine, or sertraline in the first 2-4 weeks 5
- After 4 weeks, response rates become similar to other antidepressants 5
- Particularly effective for depression accompanied by anxiety symptoms and insomnia 5, 6
Preferred Patient Populations
Mirtazapine is specifically recommended for older adults with depression 6:
- Listed among preferred agents for patients over 65 years (alongside citalopram, escitalopram, sertraline, venlafaxine, and bupropion) 6
- Better tolerated than paroxetine and fluoxetine in elderly populations 6
Pharmacokinetics
- Bioavailability: Approximately 50% 3
- Peak plasma concentration: 2.2-3.1 hours after oral administration 3
- Elimination half-life: 20-40 hours, enabling once-daily dosing 3, 4
- Metabolism: Extensively hepatic, with 85% eliminated in urine and 15% in feces 3
Adverse Effect Profile
Mirtazapine has a distinctly different side effect profile compared to SSRIs and tricyclic antidepressants 5, 3:
Common Side Effects
- Sedation/drowsiness (23% vs 14% placebo) 3
- Increased appetite (11% vs 2% placebo) 3
- Weight gain (10% vs 1% placebo) 3
- Dry mouth (25% vs 16% placebo) 3
Advantages Over Other Antidepressants
- Minimal anticholinergic effects compared to tricyclics 3
- No cardiovascular effects (no changes in blood pressure or heart rate) 3
- Essentially no sexual dysfunction 4
- Minimal gastrointestinal symptoms (unlike SSRIs) 4
- Very low seizure risk 3, 4
- Safe in overdose (up to 975 mg caused only sedation without cardiovascular, respiratory effects, or seizures) 4
Serious but Rare Adverse Events
- Agranulocytosis and neutropenia (rare, requires monitoring) 3
- Potential cardiac effects through H1-histamine receptor antagonism at therapeutic concentrations 7
Dosing
Recommended dosing regimen 3, 4:
- Initial: 15 mg once daily at bedtime for 4 days
- Standard therapeutic: 30 mg once daily after 10 days
- Maximum: 45 mg once daily if insufficient response at 30 mg
- Effective range: 15-45 mg daily
Dosage adjustments needed for hepatic or renal insufficiency with careful monitoring 3.
Chemical Structure
Mirtazapine belongs to the piperazino-azepine group with molecular formula C17H19N3 and molecular weight 265.35 1. It is a white to creamy white crystalline powder, practically insoluble in water 1.
Emerging Applications
Recent evidence suggests potential benefits beyond depression 8, 9:
- Anxiety and trauma-related disorders 10
- Irritable bowel syndrome (particularly in older patients) 9
- Cancer-related symptoms (nausea, pain, sleep disruption) 8
- Various conditions with comorbid depression 8
These effects are mediated by mirtazapine's potent antioxidative, anti-inflammatory, and anti-apoptotic properties 8.